However, RAD50 loss‐of‐function has repeatedly been linked with resistance to cytostatic agents [12, 13, 14, 15, 16, 17, 18, 19, 20], and RAD50 is regarded as one of the major contributors to cancer resistance toward chemotherapeutic drugs [21]. The gene discussed is RAD50; the disease is cancer.